Unravel Health
PrivateLast Round
Grant
Feb 20, 2025
Total Funding Raised
$161,250
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Unravel Health is a health technology company that develops a non-invasive, at-home saliva monitoring device to track hormonal patterns and biomarkers for women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Health IoT, D2C Brands, Sensors
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unravel Health Comparables
Compare Unravel Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hormona | 84% | |
| Eli Health | 84% | |
| Mint Diagnostics | 79% |
Unravel Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 20, 2025 | ||||
| Accelerator | Dec 3, 2024 | ||||
| Accelerator | Oct 25, 2024 |
Unravel Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| STAC | Accelerator |
| University of Glasgow | Accelerator |
| SBRI Healthcare | Grant |
| Health Innovation Network | Grant |
| NHS Accelerated Access Collaborative | Grant |
| Central Research Laboratory | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 60% MoM.
- Jun 20, 2026
Monthly visitors increased 37% MoM.
Recent news
Latest coverage and updates
- receives_financingOct 14, 2026
Unravel receives $3.32M in Pre Seed financing in the United Kingdom on Oct 16th '26, led by Conduit EIS Impact Fund and Wrightwood with participation from Leo Capital, Embryo Ventures, Hermesa and Zinc VC, to develop its palm-sized hormone-testing device.
Unravel Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Unravel Health's valuation, stock price, and market status.
Is Unravel Health a public or private company?
Unravel Health is a private company.
What is the current stock price of Unravel Health?
Unravel Health is a private company, so its shares have no public market price. Caplight tracks Unravel Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Unravel Health worth (valuation)?
Valuation information for Unravel Health is not publicly available.
Can I buy Unravel Health stock?
Unravel Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Unravel Health's last funding round?
Unravel Health's most recent funding round was Grant on February 20, 2025.
Who are the main investors in Unravel Health?
Key investors in Unravel Health include STAC, University of Glasgow, SBRI Healthcare, Health Innovation Network, NHS Accelerated Access Collaborative.
Will Unravel Health IPO soon?
No public IPO plans have been announced for Unravel Health.
How can I track Unravel Health secondary market activity?
Caplight tracks bids, offers, and trades in Unravel Health's shares on secondary markets.